Stephan Bernstein, CEO of GreenRoc, details the PFS results for the new graphite processing plant. Watch the video here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksIQE Regulatory News (IQE)

Share Price Information for IQE (IQE)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 29.15
Bid: 28.95
Ask: 29.20
Change: 0.70 (2.46%)
Spread: 0.25 (0.864%)
Open: 29.00
High: 29.15
Low: 28.40
Prev. Close: 28.45
IQE Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

IQE and Cardiff University extend partnership

11 Dec 2023 07:00

RNS Number : 1906W
IQE PLC
11 December 2023
 

IQE plc

 

Reach

 

Cardiff, UK

11 December 2023

 

 

IQE and Cardiff University extend long-term partnership

· Fostering compound semiconductor talent pipeline

· Advancing research and development into emerging applications

 

 

IQE plc (AIM: IQE, "IQE" or the "Group"), the leading supplier of compound semiconductor wafer products and advanced material solutions to the global semiconductor industry, is pleased to announce an extension of its partnership with Cardiff University.

This further extends a long-term collaboration between the two partners to expand research capacity in compound semiconductor technologies and skills provision at Postgraduate and Doctorial levels. It will enable the development of a talent pipeline that will support future expansion of IQE's South Wales manufacturing operations.

The partnership will extend the research and development roadmap between IQE and Cardiff University to support emerging applications in quantum systems, consumer electronics, communications infrastructure and energy efficient power electronics for Net Zero.

Americo Lemos, Chief Executive Officer of IQE, commented:

"People are at the heart of innovation in the semiconductor industry and there is a recognised shortage of talent worldwide. By strengthening our partnership with Cardiff University, we are creating a talent pipeline for the benefit of IQE and the wider South Wales semiconductor industry to underpin growth. By supporting university-level training and collaborating on research and development, together we will continue to build a resilient and competitive world-class compound semiconductor ecosystem."

 

Rudolf Allemann, Pro Vice-Chancellor, International and Student Recruitment and Head of the College of Physical Sciences and Engineering, commented:

 

"The close and focused partnership between IQE plc and Cardiff University has already delivered results, helping position South Wales as a leader in the field of semiconductor research and development. Over the next five years, we will build on that success with the partnership further benefiting industry and the regional economy."

 

Contacts:

 

IQE plc

+44 (0) 29 2083 9400

Americo Lemos

Neil Rummings

Amy Barlow

Headland Consultancy (Financial PR) + 44 (0) 20 38054822

Andy Rivett-Carnac: +44 (0) 7968 997 365

Chloe Francklin: +44 (0)78 3497 4624

 

ABOUT IQE

http://iqep.com

 

 

IQE is the leading global supplier of advanced compound semiconductor wafers and materials solutions that enable a diverse range of applications across:

 

· Smart Connected Devices

· Communications Infrastructure

· Automotive and Industrial

· Aerospace and Security

 

As a scaled global epitaxy wafer manufacturer, IQE is uniquely positioned in this market which has high barriers to entry. IQE supplies the global market and is enabling customers to innovate at chip and OEM level. By leveraging the Group's intellectual property portfolio including know-how and patents, it produces epitaxy wafers of superior quality, yield and unit economics.

IQE is headquartered in Cardiff UK, with employees across eight manufacturing locations in the UK, US and Taiwan, and is listed on the AIM Stock Exchange in London.

 

ABOUT CARDIFF UNIVERSITY

Cardiff University

 

Cardiff University is recognised in independent government assessments as one of Britain's leading teaching and research universities and is a member of the Russell Group of the UK's most research intensive universities. The 2021 Research Excellence Framework found 90% of the University's research to be world-leading or internationally excellent. Among its academic staff are two Nobel Laureates, including the winner of the 2007 Nobel Prize for Medicine, Professor Sir Martin Evans. Founded by Royal Charter in 1883, today the University combines impressive modern facilities and a dynamic approach to teaching and research. The University's breadth of expertise encompasses: the College of Arts, Humanities and Social Sciences; the College of Biomedical and Life Sciences; and the College of Physical Sciences and Engineering. Its University institutes bring together academics from a range of disciplines to tackle some of the challenges facing society, the economy, and the environment.

This information is provided by Reach, the non-regulatory press release distribution service of RNS, part of the London Stock Exchange. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
NRANKFBDKBDDOBK
Date   Source Headline
27th Jul 20062:47 pmRNSGrant of share options
20th Jul 20067:02 amRNSTrading Statement
20th Jul 20067:01 amRNSAcquisition
7th Jul 20062:46 pmRNSChange of Adviser
5th Jun 200610:32 amRNSDirector/PDMR Shareholding
30th May 20067:01 amRNSTrading Update
23rd May 200612:58 pmRNSAdditional Listing
19th May 20062:59 pmRNSHolding(s) in Company
8th May 20061:00 pmRNSAGM Notice & Board Appt
3rd May 20068:49 amRNSHolding(s) in Company
21st Apr 20066:01 pmRNSAdditional Listing
4th Apr 200612:45 pmRNSAdditional Listing
30th Mar 20064:25 pmRNSHolding(s) in Company
29th Mar 20061:51 pmRNSDirector/PDMR Shareholding
28th Mar 200611:27 amRNSHolding(s) in Company
20th Mar 20067:01 amRNSFinal Results
10th Mar 20064:33 pmRNSChange of Results Date
1st Mar 20067:01 amRNSNotice of Results
27th Jan 20067:01 amRNSContract Win
27th Jan 20067:01 amRNSPre-Close Trading Update
20th Dec 200511:58 amRNSAdditional Listing
26th Oct 20052:06 pmRNSHolding(s) in Company
20th Oct 20053:57 pmRNSDirector/PDMR Shareholding
10th Oct 20059:38 amRNSDirector/PDMR Shareholding
12th Sep 20053:09 pmRNSHolding(s) in Company
24th Aug 20057:00 amRNSInterim Results
19th Aug 200511:46 amRNSAdditional Listing
29th Jul 20057:00 amRNSNotice of Results
22nd Jul 20055:23 pmRNSHolding(s) in Company
20th Jul 20051:17 pmRNSHolding(s) in Company
19th Jul 200510:42 amRNSHolding(s) in Company
18th Jul 20053:52 pmRNSHolding(s) in Company
15th Jul 200512:54 pmRNSAdditional Listing
12th Jul 20057:30 amRNSIndustry Award Win
28th Jun 200511:47 amRNSAdditional Listing- Replace
28th Jun 200510:12 amRNSAdditional Listing
17th Jun 20059:48 amRNSHolding(s) in Company
16th Jun 200511:09 amRNSHolding(s) in Company
26th May 200511:53 amRNSAnnual Report and Accounts
25th May 20051:15 pmRNSAGM Statement
18th Apr 20053:24 pmRNSAdditional Listing
22nd Mar 20057:02 amRNSFinal Results
28th Feb 20059:33 amRNSNotice of Results
4th Feb 20051:18 pmRNSHolding(s) in Company
27th Jan 20057:00 amRNSTrading Statement
10th Jan 200511:35 amRNSAdd. Listing/Director s/hldng

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.